Strs Ohio Invests $30 Million in GE HealthCare Technologies Inc. $GEHC

Key Points

• Strs Ohio has acquired a new stake in GE HealthCare Technologies, purchasing 371,709 shares valued at approximately $30 million, representing 0.08% ownership.
• GE HealthCare Technologies reported earnings of $1.06 per share for the last quarter, exceeding expectations of $0.91, and had a revenue of $5 billion.
• Analysts have mixed opinions on GE HealthCare, with Zacks upgrading it to a "strong-buy" and Morgan Stanley lowering its price target from $78 to $74, reflecting a consensus of cautious optimism.

Strs Ohio acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 371,709 shares of the company's stock, valued at approximately $30,001,000. Strs Ohio owned about 0.08% of GE HealthCare Technologies as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. N.E.W. Advisory Services LLC purchased a new position in shares of GE HealthCare Technologies during the first quarter worth approximately $25,000. Bogart Wealth LLC raised its stake in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after buying an additional 247 shares during the last quarter. Stonebridge Financial Group LLC raised its position in shares of GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after acquiring an additional 222 shares during the period. Ameriflex Group Inc. purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $31,000. Finally, Olde Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth about $35,000. Institutional investors own 82.06% of the company's stock.

Wall Street Analyst Weigh In

GEHC has been the subject of several analyst reports. Citigroup increased their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Morgan Stanley lowered their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Finally, Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $1.52 during midday trading on Friday, hitting $76.44. 3,254,120 shares of the company traded hands, compared to its average volume of 2,969,325. The stock has a market capitalization of $34.90 billion, a price-to-earnings ratio of 15.66, a price-to-earnings-growth ratio of 2.92 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The business has a 50 day simple moving average of $74.46 and a 200-day simple moving average of $73.43. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the company earned $1.00 earnings per share. The company's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.